Agenus
AGEN
#8940
Rank
NZ$0.23 B
Marketcap
NZ$7.04
Share price
-2.64%
Change (1 day)
20.27%
Change (1 year)

Agenus (AGEN) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$79.39 Million

According to Agenus 's latest financial reports the company's total debt is NZ$79.39 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Agenus - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$0.16 B20.25%
2023-12-31NZ$0.13 B13.25%
2022-12-31NZ$0.12 B44.76%
2021-12-31NZ$85.33 M10.49%
2020-12-31NZ$77.23 M122.35%
2019-12-31NZ$34.73 M74.42%
2018-12-31NZ$19.91 M-91.32%
2017-12-31NZ$0.22 B21.67%
2016-12-31NZ$0.18 B12.8%
2015-12-31NZ$0.16 B2074.51%
2014-12-31NZ$7.69 M-28.71%
2013-12-31NZ$10.78 M3621.24%
2012-12-31NZ$0.28 M-99.31%
2011-12-31NZ$42.18 M-4.83%
2010-12-31NZ$44.32 M-35.14%
2009-12-31NZ$68.34 M-38.29%
2008-12-31NZ$0.11 B9.4%
2007-12-31NZ$0.10 B-5.51%
2006-12-31NZ$0.10 B1656.21%
2005-12-31NZ$6.1 M-56.13%
2004-12-31NZ$13.9 M-43.03%
2003-12-31NZ$24.4 M2218.99%
2002-12-31NZ$1.05 M-92.83%
2001-12-31NZ$14.68 M30.69%
2000-12-31NZ$11.23 M95.68%
1999-12-31NZ$5.74 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Merck
MRK
NZ$71.77 B 90,293.48%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$41.39 B 52,033.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
NZ$79.44 B 99,952.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$4.54 M-94.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$88.54 B 111,413.84%๐Ÿ‡บ๐Ÿ‡ธ USA